Aceragen | Ativo Circulante

Current Assets Alterar Data
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Clal Biotechnology ILS 16.64M 4.52M 2022-12
Compugen USD 60.27M 9.13M 2023-09
CSL USD 9.26B 342.6M 2023-06
Dynavax Technologies USD 859.12M 23.45M 2023-12
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Grifols EUR 5.02B 210.6M 2023-09
Pfizer USD 74.01B 665M 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09



Aceragen Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.